Pitt Prof | EvolvingSTEM | biofilms | EvMed | genomics entrepreneur (@SeqCoast.bsky.social, @midauthorbio.bsky.social) | ASM President-Elect | exercise addict ~ swim bike run
asm.org/Press-Releas...
1) genomic epidemiology,
2) global equity of access and representation, and
3) phylogenetic wizardry.
Congrats Zam and Viridian team on this tremendous resource!
a) correcting errors in 4.5 million genomes & their phylogeny
b) improving representation of the Global South in public data
www.nature.com/articles/s41...
(thread 1/n)
1) genomic epidemiology,
2) global equity of access and representation, and
3) phylogenetic wizardry.
Congrats Zam and Viridian team on this tremendous resource!
a) correcting errors in 4.5 million genomes & their phylogeny
b) improving representation of the Global South in public data
www.nature.com/articles/s41...
(thread 1/n)
a) correcting errors in 4.5 million genomes & their phylogeny
b) improving representation of the Global South in public data
www.nature.com/articles/s41...
(thread 1/n)
But, shit, Green Day is playing the damn Super Bowl so I'm happy.
But, shit, Green Day is playing the damn Super Bowl so I'm happy.
But I still have my job. Along w/a core team, we are still dedicated to covering public health, holding the powerful to account.
But I still have my job. Along w/a core team, we are still dedicated to covering public health, holding the powerful to account.
NSF discoveries underpin most modern technology from the US.
That scientific progress is ending. Tell your reps!
[OK, maybe the 1930s if you want to nitpick]
But, with some data wrangling, my first NSF Funding Curves!
2/3
NSF discoveries underpin most modern technology from the US.
That scientific progress is ending. Tell your reps!
(1) $48.7 billion for NIH
(2) Full IDC recovery
(3) No more multi-year funding
(4) No NIH reorganization, maintaining the current IC structure.
(1) $48.7 billion for NIH
(2) Full IDC recovery
(3) No more multi-year funding
(4) No NIH reorganization, maintaining the current IC structure.
Our new work at @cultivarium.bsky.social screening lots of transposon vectors in lots of bacteria, from @charliegilbert.bsky.social and team.
Transposon and promoter modular parts available on Addgene (pooled library will be there soon too)
Our new work at @cultivarium.bsky.social screening lots of transposon vectors in lots of bacteria, from @charliegilbert.bsky.social and team.
Transposon and promoter modular parts available on Addgene (pooled library will be there soon too)
joshuasweitz.substack.com/p/confrontin...
joshuasweitz.substack.com/p/confrontin...
-Sad for us because Omniome's tech (the current Onso instrument) was promising for its Q40 reads that help those interested in calling rare variants accurately (like me).
-Sad for them too because $$$
aseq.substack.com/p/pacbio-sel...
-Sad for us because Omniome's tech (the current Onso instrument) was promising for its Q40 reads that help those interested in calling rare variants accurately (like me).
-Sad for them too because $$$
aseq.substack.com/p/pacbio-sel...
buff.ly/Lu9Catr
buff.ly/Lu9Catr
📍Minneapolis, Minnesota
📍Minneapolis, Minnesota
I really do hope scientists understand what this means for the future of science (funding) - it's not subtle.
www.niaid.nih.gov/about/unifie...
I really do hope scientists understand what this means for the future of science (funding) - it's not subtle.
www.niaid.nih.gov/about/unifie...
asm.org/about-asm/as...
asm.org/about-asm/as...
We represent plasmids as circles and mutations as dots, resembling an eye, because in this paper we literally 𝑤𝑎𝑡𝑐ℎ plasmids evolve.
‼️Check Paula’s 🧵 and the paper👇
𝗣𝗹𝗮𝘀𝗺𝗶𝗱 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀 𝘀𝗰𝗮𝗹𝗲 𝘄𝗶𝘁𝗵 𝗰𝗼𝗽𝘆 𝗻𝘂𝗺𝗯𝗲𝗿
www.pnas.org/doi/10.1073/...
We represent plasmids as circles and mutations as dots, resembling an eye, because in this paper we literally 𝑤𝑎𝑡𝑐ℎ plasmids evolve.
‼️Check Paula’s 🧵 and the paper👇
𝗣𝗹𝗮𝘀𝗺𝗶𝗱 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀 𝘀𝗰𝗮𝗹𝗲 𝘄𝗶𝘁𝗵 𝗰𝗼𝗽𝘆 𝗻𝘂𝗺𝗯𝗲𝗿
www.pnas.org/doi/10.1073/...
asm.org/about-asm/as...
asm.org/about-asm/as...
Erin Gloag's review is a great starting point pubmed.ncbi.nlm.nih.gov/33447803/
Erin Gloag's review is a great starting point pubmed.ncbi.nlm.nih.gov/33447803/
Titles aside, I hope you'll read it (the tech is NOT close). Thanks to Tom Freeman for writing help & @jfischman.bsky.social for ace editing! www.scientificamerican.com/article/life...